Northeast Node of the National Drug Abuse Clinical Trials Network
国家药物滥用临床试验网络东北节点
基本信息
- 批准号:9901398
- 负责人:
- 金额:$ 37.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-01 至 2020-05-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementAdolescentAdultAlcohol or Other Drugs useAmericanAnalgesicsBehavioralCaringChronicClinicalClinical Trials NetworkCollaborationsCommunitiesCommunity NetworksComorbidityCost effectiveness researchCriminal JusticeDevelopmentDrug abuseDrug userEffectivenessEvaluationFundingGeographic LocationsHIVHIV riskHealthcare SystemsHome environmentHospitalsIndividualInfrastructureInternetInterventionKnowledgeLeadershipMaineManaged CareMedicalMental HealthMental disordersModelingNational Clinical Trials NetworkNational Institute of Drug AbuseNew HampshirePersonsPharmaceutical PreparationsPharmacologyPoliciesPopulationPractical trialPreventionPrimary Health CarePrincipal InvestigatorPublic HealthRecoveryResearchResearch InfrastructureResearch SupportResourcesRiskRisk BehaviorsRoleRural CommunitySample SizeSamplingSchoolsScienceSeminalServicesSiteSmokerSubstance Use DisorderSubstance abuse problemSystemTechnologyTherapeuticTimeTranquilizing AgentsVermontVeteransWorkYouthaddictionadolescent substance useagedbasebehavioral healthcare coordinationcare systemschronic pain patientcollegeeffectiveness trialevidence baseillicit drug useimplementation researchinsightmarijuana usemedical specialtiesopioid use disorderpaymentprescription opioidprimary care settingprogramsprovider networksranpirnaseresearch and developmentrural arearural healthcarescience educationscreeningservice deliverysubstance abuse treatmentsynergismtechnology validationtherapy developmenttool
项目摘要
Project Summary/Abstract
We propose to establish a new Node of the NIDA Clinical Trials Network (CTN) -- the Northeast Node
spanning the rural communities of New Hampshire, Vermont, and Maine. This Node will be based out of
Dartmouth College in collaboration with several large provider networks spanning over 400 adult and/or
adolescent general medical care partners, an array of addiction-specialty programs, and a national behavioral
health managed care partner. Dartmouth is an ideal home for this Node, as it also the home of the NIDA-
funded Center for Technology and Behavioral Health (CTBH), a P30 “Center of Excellence” that uses science
to inform the development, evaluation, and strategic implementation of technology (web, mobile)-based
therapeutic tools targeting substance use disorders (SUDs) and related issues (including HIV risk behavior and
psychiatric comorbidities). CTBH is led by Dr. Lisa Marsch, who will also serve as the Principal Investigator
on the proposed CTN node. Our team has led the field by enhancing the quality, pace of achievement, and
impact of scientific research focused on the application of technology to SUD and behavioral health treatment.
Our team has expertise in all stages of SUD intervention development, ranging from feasibility, acceptability,
efficacy, efficacy-effectiveness, effectiveness (including multi-site effectiveness trials), cost-effectiveness, and
implementation research in many contexts, including addiction and mental health specialty programs, medical
specialty programs, hospitals, schools, criminal justice settings, and primary care. This work has included
seminal research on the integration of SUD interventions into rural health care systems. This work has been
conducted with a wide array of populations including chronic drug users, smokers, veterans, chronic pain
patients, persons at risk for HIV, and persons with co-occurring SUDs and mental illness. Our group has
particular expertise in research with youth, ranging from screening and assessment, prevention, treatment,
recovery support, and care coordination for adolescents -- including several lines of research focused on
cannabis use and prescription opioid use disorders among youth. The Aims of this proposal are to (1) Expand
the NIDA CTN to new states in rural regions by launching the Northeast Node of the CTN and thereby
expanding our collaborations with primary care and other community treatment partners in identifying and
implementing timely and significant trials targeting SUDs, (2) Support and grow a productive research agenda
with a particular focus on CTN trials that centrally leverage technology-based tools and/or have a priority focus
on youth – both within the Northeast Node and via leadership and advisory roles within the national CTN
community, and (3) Develop and support an infrastructure to enhance synergy and support bidirectional
sharing of knowledge and resources between CTBH and the CTN. These activities will inform key scientific
discoveries and insights regarding the substance use-related needs and priorities in rural health care systems
as well as the effectiveness of technology-based interventions in a diverse array of community systems.
项目概要/摘要
我们提议建立NIDA临床试验网络(CTN)的新节点——东北节点
该节点将跨越新罕布什尔州、佛蒙特州和缅因州的农村社区。
达特茅斯学院与多个大型提供商网络合作,涵盖 400 多名成年人和/或
青少年一般医疗保健合作伙伴、一系列成瘾专业计划以及国家行为
达特茅斯是该节点的理想所在地,也是 NIDA 的所在地。
资助技术与行为健康中心 (CTBH),这是一个利用科学的 P30“卓越中心”
为基于技术(网络、移动)的开发、评估和战略实施提供信息
针对物质使用障碍 (SUD) 和相关问题(包括艾滋病毒危险行为和
CTBH 由 Lisa Marsch 博士领导,她也将担任首席研究员
在拟议的 CTN 节点上,我们的团队通过提高质量、成就速度和速度,在该领域处于领先地位。
科学研究的影响集中于技术在 SUD 和行为健康治疗中的应用。
我们的团队拥有 SUD 干预开发各个阶段的专业知识,包括可行性、可接受性、
功效、功效-效果、有效性(包括多中心有效性试验)、成本效益和
在许多情况下进行实施研究,包括成瘾和心理健康专业项目、医学
这项工作包括专业项目、医院、学校、刑事司法机构和初级保健。
这项工作是关于将 SUD 干预措施纳入农村卫生保健系统的开创性研究。
对广泛人群进行研究,包括慢性吸毒者、吸烟者、退伍军人、慢性疼痛患者
患者、艾滋病毒高危人群以及同时患有 SUD 和精神疾病的人群。
青年研究方面的特殊专业知识,包括筛查和评估、预防、治疗、
青少年的康复支持和护理协调——包括重点关注的几项研究
该提案的目的是 (1) 扩大青少年中的大麻使用和处方阿片类药物使用障碍。
通过启动 CTN 东北节点,将 NIDA CTN 扩展到农村地区的新州,从而
我们与扩大初级保健和其他社区治疗合作伙伴的合作,以确定和
针对 SUD 实施及时且重要的试验,(2) 支持和发展富有成效的研究议程
特别关注集中利用基于技术的工具和/或优先关注的 CTN 试验
青年——在东北节点内以及通过在国家 CTN 内的领导和咨询角色
(3) 开发和支持基础设施,以增强协同作用并支持双向
CTBH 和 CTN 之间的知识和资源共享将为关键科学提供信息。
关于农村卫生保健系统中与药物使用相关的需求和优先事项的发现和见解
以及基于技术的干预措施在各种社区系统中的有效性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lisa A. Marsch其他文献
Lisa A. Marsch的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lisa A. Marsch', 18)}}的其他基金
Technology-based Treatments for Substance Use Disorders
基于技术的药物使用障碍治疗
- 批准号:
10268734 - 财政年份:2021
- 资助金额:
$ 37.47万 - 项目类别:
相似国自然基金
自然接触对青少年网络问题行为的作用机制及其干预
- 批准号:72374025
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
大气污染物对青少年心理健康的影响机制研究
- 批准号:42377437
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
新发现青少年痛风易感基因OTUD4对痛风炎症的影响及调控机制研究
- 批准号:82301003
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人际压力影响青少年抑郁发展的心理与神经机制:基于自我意识的视角
- 批准号:32371118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
巨噬细胞M1型极化促进脂肪细胞肥大并抑制前脂肪细胞成脂分化在双酚F致青少年腹型肥胖中的作用机制研究
- 批准号:82373615
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Low-income mothers' and fathers' parenting practices and toddlers' self-regulation
低收入父母的养育方式和幼儿的自我调节
- 批准号:
10742570 - 财政年份:2023
- 资助金额:
$ 37.47万 - 项目类别:
Sex Differences in Psychosocial and Neurocognitive Outcomes in Adults with Moderate to Complex Congenital Heart Disease
患有中度至复杂先天性心脏病的成人心理社会和神经认知结果的性别差异
- 批准号:
10825104 - 财政年份:2023
- 资助金额:
$ 37.47万 - 项目类别:
Integrated Treatment for Enhancing Growth in Recovery during Adolescence (InTEGRA)
促进青春期恢复生长的综合治疗 (InTEGRA)
- 批准号:
10680616 - 财政年份:2023
- 资助金额:
$ 37.47万 - 项目类别:
Development of a Novel Calcium Channel Therapeutic for the Treatment of Asthma
开发治疗哮喘的新型钙通道疗法
- 批准号:
10603554 - 财政年份:2023
- 资助金额:
$ 37.47万 - 项目类别: